Cargando…

Identifying key mutations of radioresponsive genes in esophageal squamous cell carcinoma

BACKGROUND: Radiotherapy plays an important effect on the standard therapy of esophageal squamous cell carcinoma (ESCC). However, the efficacy of the therapy is limited and a few patients do not achieve satisfactory treatment results due to the existence of radiation resistance. Therefore, it is nec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xin, Wang, Yuming, Bai, Yongrui, Lu, Jun, Guo, Yuntao, Wang, Xiaohang, Rong, Ling, Tang, Jianmin, Ma, Xiumei, Ma, Jun, Zhang, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478485/ https://www.ncbi.nlm.nih.gov/pubmed/36119057 http://dx.doi.org/10.3389/fimmu.2022.1001173

Ejemplares similares

Identification of Key Genes Mutations Associated With the Radiosensitivity by Whole Exome Sequencing in Pancreatic Cancer
por: Hu, Bin, et al.
Publicado: (2021)

Genetic variant of ADH1C for predicting survival in esophageal squamous cell cancer patients who underwent postoperative radiotherapy
por: Xu, Xin, et al.
Publicado: (2022)

Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia
por: Zhu, Hongcheng, et al.
Publicado: (2015)

Identifying Long Non-coding RNA of Prostate Cancer Associated With Radioresponse by Comprehensive Bioinformatics Analysis
por: Xu, Meng, et al.
Publicado: (2020)

Altered Biological Potential and Radioresponse of Murine Tumors in Different Microenvironments
por: Lee, Ik Jae, et al.
Publicado: (2016)

Characterization of the radioresponse of human apical papilla-derived cells
por: Abe, Shigehiro, et al.
Publicado: (2011)

Characterizing the Radioresponse of Pluripotent and Multipotent Human Stem Cells
por: Lan, Mary L., et al.
Publicado: (2012)

Pathophysiological mechanisms underlying phenotypic differences in pulmonary radioresponse
por: Jackson, Isabel L., et al.
Publicado: (2016)

Hypoxia-Regulated lncRNA USP2-AS1 Drives Head and Neck Squamous Cell Carcinoma Progression
por: Tang, Jianmin, et al.
Publicado: (2022)

Single‐Nucleus Transcriptome Profiling of Locally Advanced Cervical Squamous Cell Cancer Identifies Neural‐Like Progenitor Program Associated with the Efficacy of Radiotherapy
por: Zhang, Lei, et al.
Publicado: (2023)

Corrigendum: Pathophysiological mechanisms underlying phenotypic differences in pulmonary radioresponse
por: Jackson, Isabel L., et al.
Publicado: (2017)

Screening and Identifying Cisplatin-Related Gene Mutations in Lung Squamous Cell Carcinoma
por: Li, Xiaohua, et al.
Publicado: (2020)

Evaluation of multiple immune cells and patient outcomes in esophageal squamous cell carcinoma
por: Wang, Hui, et al.
Publicado: (2023)

The Combination of T Stage and the Number of Pathologic Lymph Nodes Provides Better Prognostic Discrimination in Early-Stage Cervical Cancer With Lymph Node Involvement
por: Bai, Yongrui, et al.
Publicado: (2021)

Characterization of the Intra-tumoral B Cell Immunoglobulin Repertoire Is of Prognostic Value for Esophageal Squamous Cell Carcinoma
por: Wang, Zhizhong, et al.
Publicado: (2022)

Exploring Nitric Oxide (NO)-Releasing Celecoxib Derivatives as Modulators of Radioresponse in Pheochromocytoma Cells
por: Brandt, Florian, et al.
Publicado: (2022)

Case Report: Immune Checkpoint Inhibitors Successfully Controlled Asymptomatic Brain Metastasis in Esophageal Squamous Cell Carcinoma
por: Xiao, Linlin, et al.
Publicado: (2022)

Establishment of a 3D Model to Characterize the Radioresponse of Patient-Derived Glioblastoma Cells
por: Strand, Zoe, et al.
Publicado: (2023)

Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma
por: Li, Meng-Xiang, et al.
Publicado: (2021)

Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy
por: Zhou, Xiaogang, et al.
Publicado: (2021)

Danshensu, a major water-soluble component of Salvia miltiorrhiza, enhances the radioresponse for Lewis Lung Carcinoma xenografts in mice
por: Cao, Hong-Ying, et al.
Publicado: (2017)

Chronic hypoxia modulates tumour cell radioresponse through cytokine-inducible nitric oxide synthase
por: Berge, D L Van den, et al.
Publicado: (2001)

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
por: Ko, A, et al.
Publicado: (2014)

Fluctuation in radioresponse of HeLa cells during the cell cycle evaluated based on micronucleus frequency
por: Shimono, Hiroaki, et al.
Publicado: (2020)

Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching
por: Jing, Shao-Wu, et al.
Publicado: (2022)

Analysis of immunotherapeutic response-related signatures in esophageal squamous-cell carcinoma
por: Zheng, Bohao, et al.
Publicado: (2023)

Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy
por: Zhang, Yimin, et al.
Publicado: (2014)

Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model
por: Borst, Gerben R., et al.
Publicado: (2017)

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
por: Xu, Lei, et al.
Publicado: (2022)

A Distinct Esophageal mRNA Pattern Identifies Eosinophilic Esophagitis Patients With Food Impactions
por: Sallis, Benjamin F., et al.
Publicado: (2018)

Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
por: Cui, Yongping, et al.
Publicado: (2020)

The predictive value of peripheral blood cells and lymphocyte subsets in oesophageal squamous cell cancer patients with neoadjuvant chemoradiotherapy
por: Zhou, Jin, et al.
Publicado: (2022)

Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation
por: Li, Hongmu, et al.
Publicado: (2023)

Case Report: First-Line Immunotherapy for Esophageal Squamous Carcinoma Combined With Hypopharyngeal Squamous Carcinoma Yields Sustained Survival Benefit
por: Yang, Yi, et al.
Publicado: (2022)

The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
por: Lv, Huilai, et al.
Publicado: (2023)

Integrated bioinformatics analysis to identify key genes related to the prognosis of esophageal squamous cell carcinoma
por: Yang, Ying, et al.
Publicado: (2021)

Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model
por: Borst, Gerben R., et al.
Publicado: (2020)

StemRegenin 1 Mitigates Radiation-Mediated Hematopoietic Injury by Modulating Radioresponse of Hematopoietic Stem/Progenitor Cells
por: Hwang, You Jung, et al.
Publicado: (2023)

Potential biomarkers: Identifying powerful tumor specific T cells in adoptive cellular therapy
por: Ge, Wu, et al.
Publicado: (2022)

A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer
por: Ren, Qianhe, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ac616g7m1sn98jduv4v4vsckef